Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2012

01.12.2012

Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation

verfasst von: Pietro Turco, Antonio D’Onofrio, Giuseppe Stabile, Francesco Solimene, Vincenzo La Rocca, Filippo Vecchione, Assunta Iuliano, Natale Marrazzo, Stefano De Vivo, Ciro Cavallaro, Valter Bianchi, Alessia Agresta, Carmine Ciardiello, Antonio De Simone

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Patients with permanent atrial fibrillation (AF) who undergo cardiac resynchronization therapy (CRT) may spontaneously recover sinus rhythm during follow-up. We tested the feasibility and efficacy of electrical cardioversion attempted after 3 months of CRT in patients with permanent AF and measured the long-term maintenance of sinus rhythm.

Methods

Twenty-eight consecutive patients with permanent AF in whom CRT defibrillators had been implanted were scheduled for internal electrical cardioversion after 3 months (group A) and were compared with a control group of 27 patients (group B).

Results

In group A, 22 patients (79 %) were eligible for cardioversion; sinus rhythm was restored in 18 (82 %) of these, with no procedural complications. After 12 months, 16 patients (58 %) in group A were in sinus rhythm, compared with one group B patient who spontaneously recovered sinus rhythm (4 %, p < 0.001). On 12-month evaluation, ejection fraction had improved in both groups, but a reduction in left ventricular end-systolic volume was recorded only in group A patients (p = 0.018 versus baseline).

Conclusions

In patients with permanent AF, the rhythm control strategy consisting of internal cardioversion, performed by means of the implanted cardioverter–defibrillator after 3 months of CRT, was associated with a high rate of sinus rhythm resumption on long-term follow-up and with a better echocardiographic response to CRT than that seen in patients treated according to a rate control strategy.
Literatur
1.
Zurück zum Zitat Dickstein, K., Bogale, N., Priori, S., Auricchio, A., Cleland, J. G., Gitt, A., Limbourg, T., Linde, C., van Veldhuisen, D. J., Brugada, J., Committee, S., & Coordinators, N. (2009). The European cardiac resynchronization therapy survey. Eur Heart J, 30, 2450–2460.PubMedCrossRef Dickstein, K., Bogale, N., Priori, S., Auricchio, A., Cleland, J. G., Gitt, A., Limbourg, T., Linde, C., van Veldhuisen, D. J., Brugada, J., Committee, S., & Coordinators, N. (2009). The European cardiac resynchronization therapy survey. Eur Heart J, 30, 2450–2460.PubMedCrossRef
2.
Zurück zum Zitat Gasparini, M., Auricchio, A., Regoli, F., Fantoni, C., Kawabata, M., Galimberti, P., Pini, D., Ceriotti, C., Gronda, E., Klersy, C., Fratini, S., & Klein, H. H. (2006). Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol, 48, 734–743.PubMedCrossRef Gasparini, M., Auricchio, A., Regoli, F., Fantoni, C., Kawabata, M., Galimberti, P., Pini, D., Ceriotti, C., Gronda, E., Klersy, C., Fratini, S., & Klein, H. H. (2006). Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol, 48, 734–743.PubMedCrossRef
3.
Zurück zum Zitat Gasparini, M., Auricchio, A., Metra, M., Regoli, F., Fantoni, C., Lamp, B., Curnis, A., Vogt, J., & Klersy, C. (2008). Multicentre Longitudinal Observational Study (MILOS) Group: long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J, 29, 1644–1652.PubMedCrossRef Gasparini, M., Auricchio, A., Metra, M., Regoli, F., Fantoni, C., Lamp, B., Curnis, A., Vogt, J., & Klersy, C. (2008). Multicentre Longitudinal Observational Study (MILOS) Group: long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J, 29, 1644–1652.PubMedCrossRef
4.
Zurück zum Zitat Upadhyay, G. A., Choudhry, N. K., Auricchio, A., Ruskin, J., & Singh, J. P. (2008). Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol, 52, 1239–1246.PubMedCrossRef Upadhyay, G. A., Choudhry, N. K., Auricchio, A., Ruskin, J., & Singh, J. P. (2008). Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol, 52, 1239–1246.PubMedCrossRef
5.
Zurück zum Zitat Van Gelder, I. C., & Crijns, H. J. (1997). Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythm. Pacing Clin Electrophysiol, 20, 2675–2683.PubMedCrossRef Van Gelder, I. C., & Crijns, H. J. (1997). Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythm. Pacing Clin Electrophysiol, 20, 2675–2683.PubMedCrossRef
6.
Zurück zum Zitat Gasparini, M., Steinberg, J. S., Arshad, A., Regoli, F., Galimberti, P., Rosier, A., Daubert, J. C., Klersy, C., Kamath, G., & Leclercq, C. (2010). Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study. Eur Heart J, 31, 976–983.PubMedCrossRef Gasparini, M., Steinberg, J. S., Arshad, A., Regoli, F., Galimberti, P., Rosier, A., Daubert, J. C., Klersy, C., Kamath, G., & Leclercq, C. (2010). Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study. Eur Heart J, 31, 976–983.PubMedCrossRef
7.
Zurück zum Zitat Dittrich, H. C., Erickson, J. S., Schneiderman, T., Blacky, A. R., Savides, T., & Nicod, P. H. (1989). Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol, 63, 193–197.PubMedCrossRef Dittrich, H. C., Erickson, J. S., Schneiderman, T., Blacky, A. R., Savides, T., & Nicod, P. H. (1989). Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol, 63, 193–197.PubMedCrossRef
8.
Zurück zum Zitat European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm, A. J., Kirchhof, P., Lip, G. Y., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., Al-Attar, N., Hindricks, G., Prendergast, B., Heidbuchel, H., Alfieri, O., Angelini, A., Atar, D., Colonna, P., De Caterina, R., De Sutter, J., Goette, A., Gorenek, B., Heldal, M., Hohloser, S. H., Kolh, P., Le Heuzey, J. Y., Ponikowski, P., & Rutten, F. H. (2010). Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J, 31, 2369–2429.PubMedCrossRef European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm, A. J., Kirchhof, P., Lip, G. Y., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., Al-Attar, N., Hindricks, G., Prendergast, B., Heidbuchel, H., Alfieri, O., Angelini, A., Atar, D., Colonna, P., De Caterina, R., De Sutter, J., Goette, A., Gorenek, B., Heldal, M., Hohloser, S. H., Kolh, P., Le Heuzey, J. Y., Ponikowski, P., & Rutten, F. H. (2010). Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J, 31, 2369–2429.PubMedCrossRef
9.
Zurück zum Zitat Saxon, L. A., Greenfield, R. A., Crandall, B. G., Nydegger, C. C., Orlov, M., & Van Genderen, R. (2006). Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol, 17, 520–525.PubMedCrossRef Saxon, L. A., Greenfield, R. A., Crandall, B. G., Nydegger, C. C., Orlov, M., & Van Genderen, R. (2006). Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol, 17, 520–525.PubMedCrossRef
10.
Zurück zum Zitat Boriani, G., Biffi, M., Camanini, C., Corazza, I., Martignani, C., Valzania, C., Gallina, M., Grigioni, F., Zannoli, R., Rapezzi, C., & Branzi, A. (2004). Efficacy of internal cardioversion for chronic atrial fibrillation in patients with and without left ventricular dysfunction. Int J Cardiol, 95, 43–47.PubMedCrossRef Boriani, G., Biffi, M., Camanini, C., Corazza, I., Martignani, C., Valzania, C., Gallina, M., Grigioni, F., Zannoli, R., Rapezzi, C., & Branzi, A. (2004). Efficacy of internal cardioversion for chronic atrial fibrillation in patients with and without left ventricular dysfunction. Int J Cardiol, 95, 43–47.PubMedCrossRef
11.
Zurück zum Zitat Tse, H. F., & Lau, C. P. (1999). Safety and efficacy of internal cardioversion of atrial fibrillation in patients with impaired left ventricular systolic function. Am J Cardiol, 84, 1090–1092.PubMedCrossRef Tse, H. F., & Lau, C. P. (1999). Safety and efficacy of internal cardioversion of atrial fibrillation in patients with impaired left ventricular systolic function. Am J Cardiol, 84, 1090–1092.PubMedCrossRef
12.
Zurück zum Zitat Hügl, B., Bruns, H. J., Unterberg-Buchwald, C., Grosse, A., Stegemann, B., Lauer, B., Geller, J. C., & Gasparini, M. (2006). Atrial fibrillation burden during the post-implant period after crt using device-based diagnostics. J Cardiovasc Electrophysiol, 17, 813–817.PubMedCrossRef Hügl, B., Bruns, H. J., Unterberg-Buchwald, C., Grosse, A., Stegemann, B., Lauer, B., Geller, J. C., & Gasparini, M. (2006). Atrial fibrillation burden during the post-implant period after crt using device-based diagnostics. J Cardiovasc Electrophysiol, 17, 813–817.PubMedCrossRef
13.
Zurück zum Zitat Kiès, P., Leclercq, C., Bleeker, G. B., Crocq, C., Molhoek, S. G., Poulain, C., van Erven, L., Bootsma, M., Zeppenfeld, K., van der Wall, E. E., Daubert, J. C., Schalij, M. J., & Bax, J. J. (2006). Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart, 92, 490–494.PubMedCrossRef Kiès, P., Leclercq, C., Bleeker, G. B., Crocq, C., Molhoek, S. G., Poulain, C., van Erven, L., Bootsma, M., Zeppenfeld, K., van der Wall, E. E., Daubert, J. C., Schalij, M. J., & Bax, J. J. (2006). Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart, 92, 490–494.PubMedCrossRef
14.
Zurück zum Zitat Maisel, W. H., & Stevenson, L. W. (2003). Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol, 91, 2D–8D.PubMedCrossRef Maisel, W. H., & Stevenson, L. W. (2003). Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol, 91, 2D–8D.PubMedCrossRef
15.
Zurück zum Zitat Cazeau, S., Bordachar, P., Jauvert, G., Lazarus, A., Alonso, C., Vandrell, M. C., Mugica, J., & Ritter, P. (2003). Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study. Pacing Clin Electrophysiol, 26, 137–143.PubMedCrossRef Cazeau, S., Bordachar, P., Jauvert, G., Lazarus, A., Alonso, C., Vandrell, M. C., Mugica, J., & Ritter, P. (2003). Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study. Pacing Clin Electrophysiol, 26, 137–143.PubMedCrossRef
16.
Zurück zum Zitat Israel, C. W., & Barold, S. S. (2008). Cardiac resynchronization therapy in patients with atrial fibrillation: is atrial lead implantation necessary? Pacing Clin Electrophysiol, 31, 263–265.PubMedCrossRef Israel, C. W., & Barold, S. S. (2008). Cardiac resynchronization therapy in patients with atrial fibrillation: is atrial lead implantation necessary? Pacing Clin Electrophysiol, 31, 263–265.PubMedCrossRef
17.
Zurück zum Zitat Yu, C. M., Chau, E., Sanderson, J. E., Fan, K., Tang, M. O., Fung, W. H., Lin, H., Kong, S. L., Lam, Y. M., Hill, M. R., & Lau, C. P. (2002). Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation, 105, 438–445.PubMedCrossRef Yu, C. M., Chau, E., Sanderson, J. E., Fan, K., Tang, M. O., Fung, W. H., Lin, H., Kong, S. L., Lam, Y. M., Hill, M. R., & Lau, C. P. (2002). Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation, 105, 438–445.PubMedCrossRef
Metadaten
Titel
Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation
verfasst von
Pietro Turco
Antonio D’Onofrio
Giuseppe Stabile
Francesco Solimene
Vincenzo La Rocca
Filippo Vecchione
Assunta Iuliano
Natale Marrazzo
Stefano De Vivo
Ciro Cavallaro
Valter Bianchi
Alessia Agresta
Carmine Ciardiello
Antonio De Simone
Publikationsdatum
01.12.2012
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2012
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-012-9713-2

Weitere Artikel der Ausgabe 3/2012

Journal of Interventional Cardiac Electrophysiology 3/2012 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.